SIETES :: 93011 citas

Resultados de la búsqueda por BENFLUOREX REFINAR BÚSQUEDA

1.

Taylor P. Servier faces manslaughter trial over weight loss drug deaths. Drug shown to damage heart and thought to cause death. PMLiVE 2019:24 de septiembre. [Ref.ID 103181]

2.

Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:29 de marzo. [Ref.ID 102577]

3.

Coste J. Diverging approaches of pharmacovigilance and pharmacoepidemiology to assessing drug safety: epistemological and ethical implications. Pharmacoepidemiol Drug Saf 2017;26:600-2. [Ref.ID 101606]

4.

Anónimo. Paris prosecutor indicts drugmaker Servier, french drug regulator over benfluorex scandal. DIA Daily 2017:1. [Ref.ID 101599]

5.

Anónimo. Médicaments de l'obésité: trop de dégâts trop longtemps. Prescrire 2017;37:105. [Ref.ID 101442]

6.

Anónimo. Benfluorex: un bilan 1976-2015. Prescrire 2016;36:755. [Ref.ID 100895]

7.

Casassus B. Drug scandals in France: have the lessons been learnt?. Lancet 2016;388:550-2. [Ref.ID 100574]

8.

Stafford N. Jacques Servier. BMJ 2014;348:g3298. [Ref.ID 98043]

9.

Anónimo. Comportements violents envers autrui sous l'effet de médicaments. Prescrire 2014;34:110-3. [Ref.ID 97126]

10.

Anónimo. Valvulopathies d'origine médicamenteuse. Prescrire 2013;33:668-72. [Ref.ID 96188]

11.

Mullard A. Mediator scandal engulfs French compensation body. Lancet 2013;381:1803. [Ref.ID 95500]

12.

Deltour N, Coste M, Tupinon-Mathieu I. Letter to the editor. Pharmacoepidemiol Drug Saf 2012;21:584-5. [Ref.ID 93070]

13.

Anónimo. Recherche clinique sous influence: penser les alternatives. Prescrire 2012;32:311-4. [Ref.ID 92580]

14.

Fournier A, Zureik M. Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France. Pharmacoepidemiol Drug Saf 2012;21:343-51. [Ref.ID 92514]

15.

Benkimoun P. Appetite suppressant was probably responsible for 1300 deaths, study shows. BMJ 2012;344:e996. [Ref.ID 92377]

16.

Anónimo. Anfetaminas en España. Boletín de la Tarjeta Amarilla (Centro de Farmacovigilancia de Castilla y León) 2011:2. [Ref.ID 91964]

17.

Kmietowicz Z. Fraud agency investigates conflicts of interest inside European drug regulator. BMJ 2011;343:967. [Ref.ID 91817]

18.

Braillon A. Mediator: who's to blame?. Lancet 2011;377:2003-4. [Ref.ID 91302]

19.

Vincent L, Guardiola B, Tsouderos Y, Canet E. Mediator: who's to blame?. Lancet 2011;377:2003. [Ref.ID 91301]

20.

Waller P, Evans S. Mediator: who's to blame?. Lancet 2011;377:2022-03. [Ref.ID 91300]